Sidoti & Co. Downgrades Vascular Solutions to Neutral

Brokerage firm Sidoti & Co. Downgrades its rating on Vascular Solutions(NASDAQ:VASC). The shares have been rated Neutral. Previously, the analysts had a Buy rating on the shares. The rating by Sidoti & Co. was issued on Jul 12, 2016.

Vascular Solutions (VASC) shares turned negative on Fridays trading session with the shares closing down -0.36 points or -0.83% at a volume of 67,505. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $43.6. The peak price level was also seen at $43.6 while the days lowest was $42.77. Finally the shares closed at $42.88. The 52-week high of the shares is $44.27 while the 52-week low is $24.34. According to the latest information available, the market cap of the company is $745 M.

Vascular Solutions(VASC) last announced its earnings results on Apr 25, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $39.38M. Analysts had an estimated revenue of $38.40M. Earnings per share were $0.25. Analysts had estimated an EPS of $0.23.

Several Insider Transactions has been reported to the SEC. On May 26, 2016, Howard Root (Chief Executive Officer) sold 34,418 shares at $39.05 per share price.Also, On May 16, 2016, Martin J Emerson (director) sold 20,000 shares at $37.93 per share price.On May 16, 2016, James Hennen (Sr. VP of Finance and CFO) sold 11,785 shares at $38.12 per share price, according to the Form-4 filing with the securities and exchange commission.

Vascular Solutions Inc. is a medical device company which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products which consist of the D-Stat Dry hemostat to control surface bleeding D-Stat Flowable for preventing bleeding in subcutaneous pockets Accumed wrist positioning splints and Vasc Band inflatable compression bands and Vein products which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Vascular Solutions - Is it time to Sell?

Top Brokerage Firms are advising their investors on Vascular Solutions. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.